Green Park & Golf Ventures
Green Park & Golf Ventures is a venture capital firm focused on early-stage investments in medical-related startups. They leverage the extensive operational and financial experience of their founding partners to provide strategic solutions and a strong network to their portfolio companies. Their investments typically range from $500,000 to $2,000,000.
📥 Buy Full VC Dataset
Offices: Dallas (United States), Houston (United States), Austin (United States)
Investment Stages: Seed, Series A, Series B
Markets: Medical Devices, Therapeutics, Diagnostics, Dental, Consumer Health, Health IT, Tech/SaaS
Founded Year: 2011
Investor Type: Venture Capital
Portfolio Companies: Adient Medical, Empirical Spine, Esculon, Mission Bio, Puracath, MicroTransponder Inc, Corvion, Socrates Health Solutions, Intervene, Accuryn, Channel Medsystems, Ataia Medical, Novascan, PeriKinetics, Noninvasix, Access Vascular, Lantern Pharma, Neumentum Inc, Betaliq, Inc, Stingray Therapeutics, OncoNano Medicine, Barricade Therapeutics, Iterion Therapeutics, Esperance Pharmaceuticals, Retension Pharmaceuticals, Gregor Diagnostics, Maui Imaging, Prolocor, PerioSciences, RTRS Technologies (Replicate Dental), Silicone Arts, Supergoop!, Prima-Temp Inc, Carpe, Grow Happy, GlycosBio, AlgoMedica, Take Command Health, Cariloop, Validic, Ikonopedia Corporation, Genomenon, RADformation, Hooray Health, Proscia, Telperian, AdBm Technologies Inc, CounterFind, HyperGiant Industries, Avanta Risk Management, Work Shield, Earthview, Worlds, OneDay, Alto, eNictotine Technology Inc, MetaSaaS, Brainspace, RemindTech, SendTechnology Inc, CancerGene Connect, Semler Scientific, Phynd, Dignitana, Theranova, Kickbox, Savara, Echo Laboratories, Archeio LLC
Website: https://www.gpgventures.com
Team Page: https://www.gpgventures.com/team
Portfolio Link: https://www.gpgventures.com/investments
LinkedIn: https://www.linkedin.com/company/green-park-&-golf-ventures
Crunchbase: https://www.crunchbase.com/organization/green-park-golf-ventures
Comments
No comments yet. Be the first to comment!